Pharmaceutical Automation Market
Pharmaceutical Automation Market Forecasts to 2030 - Global Analysis By Product (Automated Equipment, Software Solutions and Services), Workflow Type (Pre-analytical, Analytical and Post-analytical), Scale of Automation, Technology, Application, End User and By Geography
According to Stratistics MRC, the Global Pharmaceutical Automation Market is accounted for $5.79 billion in 2024 and is expected to reach $9.46 billion by 2030 growing at a CAGR of 9.8% during the forecast period. Pharmaceutical automation refers to the use of technology and machinery to streamline and enhance processes within the pharmaceutical industry. This includes automating tasks such as drug formulation, packaging, labeling, and quality control to improve efficiency, reduce human error, and ensure compliance with regulatory standards. By integrating these technologies, pharmaceutical companies can enhance productivity, reduce operational costs, and ultimately deliver safer and more effective medications to patients.
According to a study conducted by the National Community Pharmacists Association in April 2020, around 90% of community pharmacies were applying for small business federal aid under the CARES Act.
Market Dynamics:
Driver:
Rising prevalence of chronic diseases
The rising prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and cancer increases the demand for efficient and scalable drug production. As pharmaceutical companies strive to meet the growing need for medications, automation technologies enhance manufacturing processes, allowing for quicker production and improved quality control. Automated systems can streamline workflows, minimize human error, and ensure consistent product quality, which is crucial for chronic disease management.
Restraint:
Complexity of integration
The complexity of integration in pharmaceutical automation arises from the need to synchronize advanced technologies with existing systems and processes, which often involves legacy equipment and diverse software platforms. This integration can be technically challenging, requiring significant time and resources to ensure compatibility and efficiency. Such complexities can lead to prolonged project timelines, increased costs, and potential disruptions in production. As a result, it impedes the market expansion.
Opportunity:
Growing shift towards customized treatments
Automation technologies enable pharmaceutical companies to quickly adapt production lines to create individualized medications, ensuring precise dosages and formulations tailored to patient needs. This agility in manufacturing reduces time-to-market for new therapies and enhances the ability to meet specific regulatory requirements. Additionally, automated systems improve data management and traceability, essential for tracking personalized treatment outcomes, thereby driving the demand for advanced automation solutions within the pharmaceutical industry.
Threat:
High initial investment
The high initial investment in pharmaceutical automation stems from the costs associated with advanced technologies, equipment, and system integration. Implementing automation solutions requires significant capital for machinery, software, and training personnel, which can be prohibitive, especially for small to mid-sized companies. This financial burden may deter investment in automation, limiting growth opportunities within the market.
Covid-19 Impact
The covid-19 pandemic significantly accelerated the pharmaceutical automation market, as companies sought to enhance efficiency and ensure safety in drug production. The urgent need for vaccines and treatments led to increased investments in automation technologies, such as robotics and AI, to streamline manufacturing processes. Additionally, the pandemic highlighted the importance of digital transformation and real-time data management in maintaining supply chain resilience. As a result, the pharmaceutical automation market is expected to grow, driven by ongoing demand for innovative solutions and improved operational efficiencies.
The cloud computing segment is expected to be the largest during the forecast period
The cloud computing segment is predicted to secure the largest market share throughout the forecast period. Cloud computing technology is revolutionizing pharmaceutical automation by providing scalable and flexible solutions for data storage, management, and analysis. It enables real-time access to critical information, facilitating seamless collaboration among research, manufacturing, and regulatory teams. By leveraging cloud technology, pharmaceutical companies can improve operational efficiency, reduce costs, and accelerate drug development timelines, ultimately leading to better patient outcomes.
The production & manufacturing segment is expected to have the highest CAGR during the forecast period
The production & manufacturing segment is anticipated to witness the highest CAGR during the forecast period fuelled by its enhanced efficiency, accuracy, and compliance in drug development. Automated systems streamline processes such as formulation, packaging, labeling, and quality control, reducing human error and increasing throughput. Automation also facilitates flexible manufacturing, allowing companies to quickly adapt to changing market demands and personalized medicine. Overall, these applications contribute to improved operational efficiency and faster time-to-market for pharmaceuticals.
Region with largest share:
Asia Pacific is expected to register the largest market share during the forecast period driven by rising prevalence of chronic diseases. Countries like China and India are investing heavily in automation technologies. The region's growing pharmaceutical industry, coupled with advancements in robotics, artificial intelligence, and machine learning, is facilitating this transformation. Additionally, the ongoing focus on research and development, along with an expanding biopharmaceutical sector, is further propelling the adoption of automation solutions across the region.
Region with highest CAGR:
North America is projected to witness the highest CAGR over the forecast period. The United States and Canada are leading this trend, with investments in robotics, artificial intelligence, and advanced manufacturing systems to enhance operational efficiency and ensure regulatory compliance. The region's strong emphasis on research and development, alongside the rising demand for personalized medicine and biologics, is fueling the adoption of automation technologies. Furthermore, the covid-19 pandemic has accelerated the push towards automation, emphasizing the need for resilient and agile manufacturing processes.
Key players in the market
Some of the key players profiled in the Pharmaceutical Automation Market include Siemens AG, Rockwell Automation Inc., ABB Limited, Honeywell International Inc., Emerson Electric Corporation, Schneider Electric SE, Mitsubishi Electric Corporation, Bosch Rexroth AG, Yokogawa Electric Corporation, Omron Corporation, KUKA AG, Fanuc Corporation, Adept Technology Inc., Parker Hannifin Corporation, Datalogic S.p.A., Panasonic Corporation, GE Healthcare, Ametek Inc., Festo AG & Co. KG, B&R Industrial Automation, ArisGlobal and Beckhoff Automation GmbH.
Key Developments:
In May 2024, ArisGlobal unveiled its enhanced LifeSphere Automation Engine, a significant advancement aimed at revolutionizing the pharmaceutical industry’s safety and regulatory processes. This launch emphasizes the integration of artificial intelligence (AI) into the company's existing framework, enabling pharmaceutical organizations to streamline their operations and enhance data management capabilities.
In April 2024, GE Healthcare unveiled its suite of AI-Enhanced Personalized Oncology Solutions. This innovative technology is designed to significantly improve the precision and effectiveness of cancer treatments through advanced automation and machine learning techniques. This personalization is expected to enhance outcomes by aligning therapies more closely with patients' specific cancer profiles.
Products Covered:
• Automated Equipment
• Software Solutions
• Services
Workflow Types Covered:
• Pre-analytical
• Analytical
• Post-analytical
Scale of Automations Covered:
• Manual Integration
• Partial Automation
• Full Automation
Technologies Covered:
• Artificial Intelligence (AI)
• Internet of Things (IoT)
• Machine Learning
• Cloud Computing
• Data Analytics
• Other Technologies
Applications Covered:
• Drug Discovery
• Clinical Trials
• Production & Manufacturing
• Quality Control & Assurance
• Regulatory Compliance
• Other Applications
End Users Covered:
• Pharmaceutical Manufacturers
• Contract Research Organizations (CROs)
• Contract Manufacturing Organizations (CMOs)
• Biotechnology Companies
• Research Institutions
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Pharmaceutical Automation Market, By Product
5.1 Introduction
5.2 Automated Equipment
5.2.1 Robotics
5.2.2 Automated Guided Vehicles (AGVs)
5.2.3 Automated Storage & Retrieval Systems (AS/RS)
5.3 Software Solutions
5.3.1 Manufacturing Execution Systems (MES)
5.3.2 Laboratory Information Management Systems (LIMS)
5.3.3 Supply Chain Management Software
5.4 Services
5.4.1 Consulting
5.4.2 Integration Services
5.4.3 Maintenance & Support
6 Global Pharmaceutical Automation Market, By Workflow Type
6.1 Introduction
6.2 Pre-analytical
6.3 Analytical
6.4 Post-analytical
7 Global Pharmaceutical Automation Market, By Scale of Automation
7.1 Introduction
7.2 Manual Integration
7.3 Partial Automation
7.4 Full Automation
8 Global Pharmaceutical Automation Market, By Technology
8.1 Introduction
8.2 Artificial Intelligence (AI)
8.3 Internet of Things (IoT)
8.4 Machine Learning
8.5 Cloud Computing
8.6 Data Analytics
8.7 Other Technologies
9 Global Pharmaceutical Automation Market, By Application
9.1 Introduction
9.2 Drug Discovery
9.3 Clinical Trials
9.4 Production & Manufacturing
9.5 Quality Control & Assurance
9.6 Regulatory Compliance
9.7 Other Applications
10 Global Pharmaceutical Automation Market, By End User
10.1 Introduction
10.2 Pharmaceutical Manufacturers
10.3 Contract Research Organizations (CROs)
10.4 Contract Manufacturing Organizations (CMOs)
10.5 Biotechnology Companies
10.6 Research Institutions
10.7 Other End Users
11 Global Pharmaceutical Automation Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Siemens AG
13.2 Rockwell Automation Inc.
13.3 ABB Limited
13.4 Honeywell International Inc.
13.5 Emerson Electric Corporation
13.6 Schneider Electric SE
13.7 Mitsubishi Electric Corporation
13.8 Bosch Rexroth AG
13.9 Yokogawa Electric Corporation
13.10 Omron Corporation
13.11 KUKA AG
13.12 Fanuc Corporation
13.13 Adept Technology Inc.
13.14 Parker Hannifin Corporation
13.15 Datalogic S.p.A.
13.16 Panasonic Corporation
13.17 GE Healthcare
13.18 Ametek Inc.
13.19 Festo AG & Co. KG
13.20 B&R Industrial Automation
13.21 ArisGlobal
13.22 Beckhoff Automation GmbH
List of Tables
1 Global Pharmaceutical Automation Market Outlook, By Region (2022-2030) ($MN)
2 Global Pharmaceutical Automation Market Outlook, By Product (2022-2030) ($MN)
3 Global Pharmaceutical Automation Market Outlook, By Automated Equipment (2022-2030) ($MN)
4 Global Pharmaceutical Automation Market Outlook, By Robotics (2022-2030) ($MN)
5 Global Pharmaceutical Automation Market Outlook, By Automated Guided Vehicles (AGVs) (2022-2030) ($MN)
6 Global Pharmaceutical Automation Market Outlook, By Automated Storage & Retrieval Systems (AS/RS) (2022-2030) ($MN)
7 Global Pharmaceutical Automation Market Outlook, By Software Solutions (2022-2030) ($MN)
8 Global Pharmaceutical Automation Market Outlook, By Manufacturing Execution Systems (MES) (2022-2030) ($MN)
9 Global Pharmaceutical Automation Market Outlook, By Laboratory Information Management Systems (LIMS) (2022-2030) ($MN)
10 Global Pharmaceutical Automation Market Outlook, By Supply Chain Management Software (2022-2030) ($MN)
11 Global Pharmaceutical Automation Market Outlook, By Services (2022-2030) ($MN)
12 Global Pharmaceutical Automation Market Outlook, By Consulting (2022-2030) ($MN)
13 Global Pharmaceutical Automation Market Outlook, By Integration Services (2022-2030) ($MN)
14 Global Pharmaceutical Automation Market Outlook, By Maintenance & Support (2022-2030) ($MN)
15 Global Pharmaceutical Automation Market Outlook, By Workflow Type (2022-2030) ($MN)
16 Global Pharmaceutical Automation Market Outlook, By Pre-analytical (2022-2030) ($MN)
17 Global Pharmaceutical Automation Market Outlook, By Analytical (2022-2030) ($MN)
18 Global Pharmaceutical Automation Market Outlook, By Post-analytical (2022-2030) ($MN)
19 Global Pharmaceutical Automation Market Outlook, By Scale of Automation (2022-2030) ($MN)
20 Global Pharmaceutical Automation Market Outlook, By Manual Integration (2022-2030) ($MN)
21 Global Pharmaceutical Automation Market Outlook, By Partial Automation (2022-2030) ($MN)
22 Global Pharmaceutical Automation Market Outlook, By Full Automation (2022-2030) ($MN)
23 Global Pharmaceutical Automation Market Outlook, By Technology (2022-2030) ($MN)
24 Global Pharmaceutical Automation Market Outlook, By Artificial Intelligence (AI) (2022-2030) ($MN)
25 Global Pharmaceutical Automation Market Outlook, By Internet of Things (IoT) (2022-2030) ($MN)
26 Global Pharmaceutical Automation Market Outlook, By Machine Learning (2022-2030) ($MN)
27 Global Pharmaceutical Automation Market Outlook, By Cloud Computing (2022-2030) ($MN)
28 Global Pharmaceutical Automation Market Outlook, By Data Analytics (2022-2030) ($MN)
29 Global Pharmaceutical Automation Market Outlook, By Other Technologies (2022-2030) ($MN)
30 Global Pharmaceutical Automation Market Outlook, By Application (2022-2030) ($MN)
31 Global Pharmaceutical Automation Market Outlook, By Drug Discovery (2022-2030) ($MN)
32 Global Pharmaceutical Automation Market Outlook, By Clinical Trials (2022-2030) ($MN)
33 Global Pharmaceutical Automation Market Outlook, By Production & Manufacturing (2022-2030) ($MN)
34 Global Pharmaceutical Automation Market Outlook, By Quality Control & Assurance (2022-2030) ($MN)
35 Global Pharmaceutical Automation Market Outlook, By Regulatory Compliance (2022-2030) ($MN)
36 Global Pharmaceutical Automation Market Outlook, By Other Applications (2022-2030) ($MN)
37 Global Pharmaceutical Automation Market Outlook, By End User (2022-2030) ($MN)
38 Global Pharmaceutical Automation Market Outlook, By Pharmaceutical Manufacturers (2022-2030) ($MN)
39 Global Pharmaceutical Automation Market Outlook, By Contract Research Organizations (CROs) (2022-2030) ($MN)
40 Global Pharmaceutical Automation Market Outlook, By Contract Manufacturing Organizations (CMOs) (2022-2030) ($MN)
41 Global Pharmaceutical Automation Market Outlook, By Biotechnology Companies (2022-2030) ($MN)
42 Global Pharmaceutical Automation Market Outlook, By Research Institutions (2022-2030) ($MN)
43 Global Pharmaceutical Automation Market Outlook, By Other End Users (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
